{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:16:48Z","timestamp":1777450608240,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fatigue has a detrimental impact on health-related quality of life and functioning in patients with Crohn\u2019s disease (CD). We aimed to confirm the relevance and importance of fatigue, establish the content validity of the Functional Assessment of Chronic Illness Therapy\u2013Fatigue (FACIT-F), qualitatively explore meaningful change in fatigue experience, and assess the measurement properties of the FACIT-F in patients with moderate-to-severe CD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a mixed-methods observational study consisting of a cross-sectional qualitative interview (Part A) and a longitudinal 2-week daily diary pilot study (Part B) in participants aged\u2009\u2265\u200918\u00a0years with a clinical diagnosis of moderate-to-severe CD. Part A included open-ended questions related to the participant\u2019s overall experiences with CD, fatigue, and impact on daily activities and a cognitive debriefing of several patient-reported outcomes (PROs), including the FACIT-F. Part B consisted of participants completing an electronic daily diary that included the FACIT-F and other PROs for 14\u00a0days. Item performance, test\u2013retest reliability, and construct validity were assessed at baseline (Day 1), Day 7, and Day 14.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-five participants (mean age 45.1\u00a0years; 65.7% female) completed an interview (Part A). Ninety-one percent of the interview participants reported fatigue as a symptom attributed to CD. Participants indicated that fatigue had a major impact on their daily activities (e.g., recreation\/ hobbies, work\/school, yard work and housework), social activities, and emotional health. The FACIT-F was well understood by the interview participants.<\/jats:p>\n                <jats:p>Seventy-six participants (mean age 41.9\u00a0years; 66% female) completed at least the Day 1 diary entry (Part B). Potential floor and ceiling effects were observed for several FACIT-F items, but test\u2013retest reliability and construct validity were all strong and within the ranges hypothesized a priori.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The interviews indicate that fatigue is a frequent and bothersome symptom experienced by most patients with moderate-to-severe CD and support the content validity of the FACIT-F in this population. Daily diary study results indicate that the FACIT-F scale demonstrates adequate reliability and validity among patients with CD. These study findings suggest that the FACIT-F would be a reliable, valid, and useful measure of fatigue in patients with moderate-to-severe CD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-023-00612-9","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:01:40Z","timestamp":1689847300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Experience and measurement of fatigue in adults with Crohn\u2019s disease: results from qualitative interviews and a longitudinal 2-week daily diary pilot study"],"prefix":"10.1186","volume":"7","author":[{"given":"Miguel","family":"Regueiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Delbecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8412-9175","authenticated-orcid":false,"given":"Theresa","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Stassek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gale","family":"Harding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"612_CR1","doi-asserted-by":"publisher","first-page":"g6670","DOI":"10.1136\/bmj.g6670","volume":"349","author":"R Kalla","year":"2014","unstructured":"Kalla R, Ventham NT, Satsangi J, Arnott ID (2014) Crohn\u2019s disease. BMJ 349:g6670. https:\/\/doi.org\/10.1136\/bmj.g6670","journal-title":"BMJ"},{"key":"612_CR2","unstructured":"Mills SC, von Roon AC, Tekkis PP, Orchard TR. Crohn's disease. BMJ Clin Evid. 2011;2011."},{"issue":"7","key":"612_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/MIB.0b013e318281327f","volume":"19","author":"L Dibley","year":"2013","unstructured":"Dibley L, Norton C (2013) Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample. Inflamm Bowel Dis 19(7):1450\u20131462. https:\/\/doi.org\/10.1097\/MIB.0b013e318281327f","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"612_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018) ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol 113(4):481\u2013517. https:\/\/doi.org\/10.1038\/ajg.2018.27","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"612_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.crohns.2013.07.006","volume":"8","author":"DR van Langenberg","year":"2014","unstructured":"van Langenberg DR, Della Gatta P, Warmington SA, Kidgell DJ, Gibson PR, Russell AP (2014) Objectively measured muscle fatigue in Crohn\u2019s disease: correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis 8(2):137\u2013146. https:\/\/doi.org\/10.1016\/j.crohns.2013.07.006","journal-title":"J Crohns Colitis"},{"issue":"5","key":"612_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/SGA.0000000000000395","volume":"42","author":"M Wahlin","year":"2019","unstructured":"Wahlin M, Stjernman H, Munck B (2019) Disease-related worries in persons with Crohn disease: an interview study. Gastroenterol Nurs 42(5):435\u2013442. https:\/\/doi.org\/10.1097\/SGA.0000000000000395","journal-title":"Gastroenterol Nurs"},{"issue":"9","key":"612_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ecco-jcc\/jjv091","volume":"9","author":"T Grimstad","year":"2015","unstructured":"Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A et al (2015) Fatigue in newly diagnosed inflammatory bowel disease. J Crohns Colitis 9(9):725\u2013730. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv091","journal-title":"J Crohns Colitis"},{"issue":"12","key":"612_CR8","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1111\/j.1572-0241.2005.00360.x","volume":"100","author":"F Casellas","year":"2005","unstructured":"Casellas F, Vivancos JL, Sampedro M, Malagelada JR (2005) Relevance of the phenotypic characteristics of Crohn\u2019s disease in patient perception of health-related quality of life. Am J Gastroenterol 100(12):2737\u20132742. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.00360.x","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"612_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1046\/j.1365-2036.2002.01323.x","volume":"16","author":"RD Cohen","year":"2002","unstructured":"Cohen RD (2002) The quality of life in patients with Crohn\u2019s disease. Aliment Pharmacol Ther 16(9):1603\u20131609. https:\/\/doi.org\/10.1046\/j.1365-2036.2002.01323.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"612_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10620-014-3368-z","volume":"60","author":"DN Floyd","year":"2015","unstructured":"Floyd DN, Langham S, Severac HC, Levesque BG (2015) The economic and quality-of-life burden of Crohn\u2019s disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci 60(2):299\u2013312. https:\/\/doi.org\/10.1007\/s10620-014-3368-z","journal-title":"Dig Dis Sci"},{"issue":"8","key":"612_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/apt.12659","volume":"39","author":"BL Cohen","year":"2014","unstructured":"Cohen BL, Zoega H, Shah SA, Leleiko N, Lidofsky S, Bright R et al (2014) Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther 39(8):811\u2013822. https:\/\/doi.org\/10.1111\/apt.12659","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"612_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-2036.2010.04498.x","volume":"33","author":"LP Jelsness-Jorgensen","year":"2011","unstructured":"Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA (2011) Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 33(1):106\u2013114. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04498.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"612_CR13","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/ibd.21285","volume":"16","author":"MJ Romberg-Camps","year":"2010","unstructured":"Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG et al (2010) Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 16(12):2137\u20132147. https:\/\/doi.org\/10.1002\/ibd.21285","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"612_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2036.2010.04347.x","volume":"32","author":"DR van Langenberg","year":"2010","unstructured":"van Langenberg DR, Gibson PR (2010) Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 32(2):131\u2013143. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04347.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"612_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.crohns.2014.01.004","volume":"8","author":"W Czuber-Dochan","year":"2014","unstructured":"Czuber-Dochan W, Norton C, Bredin F, Darvell M, Nathan I, Terry H (2014) Healthcare professionals\u2019 perceptions of fatigue experienced by people with IBD. J Crohns Colitis 8(8):835\u2013844. https:\/\/doi.org\/10.1016\/j.crohns.2014.01.004","journal-title":"J Crohns Colitis"},{"key":"612_CR16","volume-title":"The FACIT-Fatigue Scale: Description Reliability and Validity","author":"D Cella","year":"2003","unstructured":"Cella D, Beaumont J (2003) The FACIT-Fatigue Scale: Description Reliability and Validity. Center on Outcomes, Research and Education, Evanston"},{"issue":"2","key":"612_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528\u2013538. https:\/\/doi.org\/10.1002\/cncr.10245","journal-title":"Cancer"},{"issue":"11\u201312","key":"612_CR18","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/j.1365-2036.2011.04871.x","volume":"34","author":"A Tinsley","year":"2011","unstructured":"Tinsley A, Macklin EA, Korzenik JR, Sands BE (2011) Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther 34(11\u201312):1328\u20131336. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04871.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"612_CR19","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J et al (2008) Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 111(4):1840\u20131847. https:\/\/doi.org\/10.1182\/blood-2007-06-094136","journal-title":"Blood"},{"issue":"5","key":"612_CR20","first-page":"811","volume":"32","author":"D Cella","year":"2005","unstructured":"Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J (2005) Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32(5):811\u2013819","journal-title":"J Rheumatol"},{"issue":"7","key":"612_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2006.065763","volume":"66","author":"V Chandran","year":"2007","unstructured":"Chandran V, Bhella S, Schentag C, Gladman DD (2007) Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Ann Rheum Dis 66(7):936\u2013939. https:\/\/doi.org\/10.1136\/ard.2006.065763","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"612_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/ecco-jcc\/jjz024","volume":"13","author":"C Chavarria","year":"2019","unstructured":"Chavarria C, Casanova MJ, Chaparro M, Barreiro-de Acosta M, Ezquiaga E, Bujanda L et al (2019) Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study. J Crohns Colitis 13(8):996\u20131002. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz024","journal-title":"J Crohns Colitis"},{"issue":"5","key":"612_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jpainsymman.2006.05.021","volume":"32","author":"P Hagell","year":"2006","unstructured":"Hagell P, Hoglund A, Reimer J, Eriksson B, Knutsson I, Widner H et al (2006) Measuring fatigue in Parkinson\u2019s disease: a psychometric study of two brief generic fatigue questionnaires. J Pain Symptom Manag 32(5):420\u2013432. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.05.021","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"612_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3899\/jrheum.100799","volume":"38","author":"JS Lai","year":"2011","unstructured":"Lai JS, Beaumont JL, Ogale S, Brunetta P, Cella D (2011) Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol 38(4):672\u2013679. https:\/\/doi.org\/10.3899\/jrheum.100799","journal-title":"J Rheumatol"},{"key":"612_CR25","doi-asserted-by":"crossref","unstructured":"Health UDo, Evaluation HSFCfD, gov Rlbfh, Health UDo, Evaluation HSFCfB, gov Rtsfh, et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Quality Life Outcomes. 2006;4(1):79.","DOI":"10.1186\/1477-7525-4-79"},{"issue":"2","key":"612_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/105294199277860","volume":"6","author":"JR Dixon Jr","year":"1998","unstructured":"Dixon JR Jr (1998) The international conference on harmonization good clinical practice guideline. Qual Assur 6(2):65\u201374. https:\/\/doi.org\/10.1080\/105294199277860","journal-title":"Qual Assur"},{"issue":"1","key":"612_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough?: An experiment with data saturation and variability. Field Methods 18(1):59\u201382","journal-title":"Field Methods"},{"issue":"4","key":"612_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC (2017) Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res 27(4):591\u2013608. https:\/\/doi.org\/10.1177\/1049732316665344","journal-title":"Qual Health Res"},{"issue":"3","key":"612_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jpsychires.2011.12.001","volume":"46","author":"SD Targum","year":"2012","unstructured":"Targum SD, Hassman H, Pinho M, Fava M (2012) Development of a clinical global impression scale for fatigue. J Psychiatr Res 46(3):370\u2013374. https:\/\/doi.org\/10.1016\/j.jpsychires.2011.12.001","journal-title":"J Psychiatr Res"},{"key":"612_CR30","unstructured":"Friese SR, T. ATLAS.ti 7 User Guide and Reference. ATLASti Scientific Software Development GmBH; . 2013."},{"issue":"5","key":"612_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00019053-200826050-00002","volume":"26","author":"NK Leidy","year":"2008","unstructured":"Leidy NK, Vernon M (2008) Perspectives on patient-reported outcomes\u202f: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 26(5):363\u2013370. https:\/\/doi.org\/10.2165\/00019053-200826050-00002","journal-title":"Pharmacoeconomics"},{"key":"612_CR32","unstructured":"United States Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register. 2009;74(2355)."},{"issue":"1","key":"612_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2036.2011.04914.x","volume":"35","author":"P Bager","year":"2012","unstructured":"Bager P, Befrits R, Wikman O, Lindgren S, Moum B, Hjortswang H et al (2012) Fatigue in out-patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 35(1):133\u2013141. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04914.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"612_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/art.20539","volume":"51","author":"I Rupp","year":"2004","unstructured":"Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos GA (2004) Impact of fatigue on health-related quality of life in rheumatoid arthritis. Arthritis Rheum 51(4):578\u2013585. https:\/\/doi.org\/10.1002\/art.20539","journal-title":"Arthritis Rheum"},{"issue":"1","key":"612_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/2159676X.2017.1393221","volume":"10","author":"B Smith","year":"2018","unstructured":"Smith B (2018) Generalizability in qualitative research: Misunderstandings, opportunities and recommendations for the sport and exercise sciences. Qual Res Sport Exercise Health 10(1):137\u2013149","journal-title":"Qual Res Sport Exercise Health"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-023-00612-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T10:04:35Z","timestamp":1689847475000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-023-00612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1186\/s41687-023-00612-9","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with good clinical practice guidelines, including International Conference on Harmonization guidelines. In addition, all applicable local laws and regulatory requirements were adhered to throughout the study. Before participants were recruited, all study documents were submitted and approved by the Advarra IRB; the approval number is Pro00046399.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients and clinicians who participated in this study provided consent for the publication of their information and responses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LD and THG are employees and shareholders of Eli Lilly and Company, which provided financial support for this study. LS and GH are employees of Evidera, which performed this research. JDL consulted or served on an advisory board for Eli Lilly and company, Samsung Bioepis, UCB, Bristol-Myers Squibb, Nestle Health Science, Merck, Celgene, Janssen Pharmaceuticals, Bridge Biotherapeutics, Entasis Therapeutics, AbbVie, Pfizer, Gilead, Arena Pharmaceuticals, Protagonist Therapeutics, Amgen, and Scipher Medicine. He has received research funding from Nestle Health Science, Takeda, Janssen Pharmaceuticals, and AbbVie. He has performed legal work on behalf of generic manufacturers of ranitidine, including L. Perrigo Company; Glenmark Pharmaceuticals, Inc.; Amneal Pharmaceuticals, LLC; Aurobindo Pharma USA, Inc.; Dr. Reddy\u2019s Laboratories, Inc.; Novitium Pharma; Ranbaxy, Inc.; Sun Pharmaceutical Industries, Inc.; Strides Pharma, Inc.; and Wockhardt USA, LLC. He owns stock in Dark Canyon Labs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}